PRE 14A

PROXY STATEMENT

Company: Semnur Pharmaceuticals, Inc.
Filed: March 20, 2025
Period of Report: March 20, 2025
Accession Number: 0001213900-25-025610

View Document ↗ View on SEC.gov ↗